Clinical Trial Update: Comparing the Effects of Vitamin E, Ursodeoxycholic Acid and Pentoxyfylline on Egyptian Non-alcoholic Steatohepatitis (NASH) Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing vitamin E, ursodeoxycholic acid, and pentoxifylline in Egyptian patients with nonalcoholic steatohepatitis (NASH) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• Pentoxifylline (pentoxifylline)
• Ursodeoxycholic acid (ursodeoxycholic acid)
• Vitamin E (tocopherol)

Snippet

Sponsor: Kafrelsheikh University | Conditions: Nonalcoholic Steatohepatitis (NASH) | Phase 4 | Status: COMPLETED